Hims argued that the agency ignored the company’s disclosures and misapplied federal law on subscriptions and privacy.

Hims & Hers Health ($HIMS) filed a motion on October 22 seeking dismissal of a federal lawsuit brought by the Federal Trade ...

Hims & Hers Health moved to dismiss the US Federal Trade Commission's claims that it illegally shared consumers' health information with third-party advertising platforms, pointing the court to its ...

Hims & Hers Health trades slightly down at $29.21 today amid new testosterone therapies launch and ongoing regulatory risks.

Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Hims & Hers Health, Inc. (“Hims & Hers ...

Well, have no fear, telehealth giant Hims is here to capitalize on…er, help address your feelings of inadequacy by offering testosterone replacement therapy service. The company announced Wednesday ...

YieldMax HIMS Option Income Strategy ETF (HIYY) announces weekly distribution of $0.1416, -18.76% lower than the prior week's distribution of $0.1743. The annual distribution rate is 65.31%, with an ...

Hims & Hers Expands Operations By Launching Hims Brand Nationwide In Australia CI Aug. 31 Hims & Hers Health Expands in Australia With Pilot Rebrand MT Aug. 31 Hims & Hers offers GLP-1 weight-loss ...

Hims & Hers Health, Inc. (NYSE: HIMS), the leading global health and wellness platform, today announced the launch of new ...

The company plans to offer testosterone replacement therapy, marking its first foray into prescribing controlled substances.

Hims & Hers Health trades at $29.21 today, up 3.82% after launching an online weight management service in Germany.